KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $65.50 $80.00 Friday, 26th Apr 2024 AXSM stock ended at $71.71. This is 0.266% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $69.70 to a day high of $72.43.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Mar 07, 2016 $7.31 $7.83 $6.75 $7.25 44 800
Mar 04, 2016 $8.23 $8.33 $6.55 $7.10 40 500
Mar 03, 2016 $8.29 $8.37 $7.62 $8.30 16 200
Mar 02, 2016 $8.20 $8.44 $8.01 $8.44 4 200
Mar 01, 2016 $8.03 $8.24 $7.65 $8.18 16 300
Feb 29, 2016 $8.42 $8.50 $7.77 $7.77 17 900
Feb 26, 2016 $7.87 $8.60 $7.77 $8.40 16 600
Feb 25, 2016 $8.36 $8.36 $7.22 $7.89 54 100
Feb 24, 2016 $8.62 $8.62 $8.00 $8.38 15 800
Feb 23, 2016 $8.55 $8.71 $7.77 $8.65 14 300
Feb 22, 2016 $8.15 $8.75 $7.42 $8.65 41 400
Feb 19, 2016 $8.26 $8.65 $7.36 $8.65 11 700
Feb 18, 2016 $8.32 $8.70 $7.77 $8.39 12 500
Feb 17, 2016 $8.50 $8.50 $7.62 $8.21 26 300
Feb 16, 2016 $8.16 $8.50 $8.16 $8.25 8 100
Feb 12, 2016 $8.34 $8.34 $7.44 $8.00 2 000
Feb 11, 2016 $7.60 $8.29 $6.79 $6.85 7 200
Feb 10, 2016 $6.18 $7.00 $5.80 $6.94 8 600
Feb 09, 2016 $5.51 $7.80 $5.50 $6.30 9 100
Feb 08, 2016 $7.25 $7.25 $5.37 $5.37 26 900
Feb 05, 2016 $7.29 $7.58 $7.21 $7.21 10 300
Feb 04, 2016 $7.23 $7.80 $7.01 $7.37 12 500
Feb 03, 2016 $7.20 $7.40 $6.75 $7.32 21 200
Feb 02, 2016 $7.85 $8.15 $6.68 $7.33 27 500
Feb 01, 2016 $7.85 $8.10 $7.22 $7.71 42 400
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT